In the mid-1990s, the clinical care of patients with HIV infection changed fundamentally as a result of the development and introduction of effective antiretroviral therapy (ART). This led to dramatic reductions in the numbers of patients under care with advanced immunodeficiency. Over subsequent years care has continued to evolve for a number of reasons.
This is a new guideline. The aim is to present a consensus regarding the standard assessment and investigation at diagnosis of HIV infection and to describe the appropriate monitoring of HIV-positive individuals both on and off ART.
These guidelines have now been archived. Click here to view the latest version.
D Asboe, C Aitken, M Boffito, C Booth, P Cane, A Fakoya, AM Geretti, P Kelleher, N Mackie, D Muir, G Murphy, C Orkin, F Post, G Rooney, C Sabin, L Sherr, E Smit, W Tong, A Ustianowski, M Valappil, J Walsh, M Williams and D Yirrell on behalf of the BHIVA Guidelines Subcommittee
(See Appendix for full list of members of the BHIVA Guidelines Writing Group on Routine Investigation and Monitoring.)
HIV Medicine (2012), 13, 1–44.